SCHEMBL1157782

SCHEMBL1157782

Nc1cccc(C(=O)O)c1S

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.61
MAPT P10636 4/20 0.50
G6PD P11413 1/20 0.50
CASP7 P55210 1/20 0.50
CASP6 P55212 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
ALDH1A1 P00352 3/20 0.48
ALOX15 P16050 1/20 0.48
CDC25B P30305 1/20 0.46
GAA P10253 1/20 0.45
NAPRT Q6XQN6 2/20 0.44
IDO1 P14902 1/20 0.44
KDM4E B2RXH2 4/20 0.44
HSD17B10 Q99714 3/20 0.44
NPC1 O15118 1/20 0.44
CASP3 P42574 1/20 0.44
RAB9A P51151 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7561679 0.98 MMP2 (0.59) MMP2MAPTG6PDCASP7CASP6
SCHEMBL716946 0.84 MAPT (0.47) MMP2MAPTG6PDCASP7CASP6
SCHEMBL2162181 0.84 MAPT (0.61) MMP2MAPTG6PDCASP7CASP6
Anthranilic Acid SCHEMBL10796421 0.79 ALDH1A1 (0.62) MMP2MAPTG6PDCASP7CASP6
Potassium Ion SCHEMBL7561669 0.79 MMP2 (0.42) MMP2MAPTG6PDCASP7CASP6
SCHEMBL73593 0.77 G6PD (0.65) MMP2MAPTG6PDCASP7CASP6
SCHEMBL30797265 0.77 G6PD (0.65) MMP2MAPTG6PDCASP7CASP6
SCHEMBL8511204 0.77 MAPT (0.67) MMP2MAPTG6PDCASP7CASP6
Anthranilic Acid SCHEMBL675 0.77 ALDH1A1 (0.65) MMP2MAPTG6PDCASP7CASP6
Anthranilic Acid SCHEMBL3110791 0.77 ALDH1A1 (0.65) MMP2MAPTG6PDCASP7CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 EP claimed
US-6437178-B2 REACTING A HALOGENATED BENZENE COMPOUND WITH NITRO(THIO)PHENOL; REDUCTION INFINEON TECHNOLOGIES AG (DE) 2002-08-20 US claimed
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid SIEMENS AKTIENGESELLSCHAFT 2001-12-27 US claimed
EP-0905124-B1 o-amino(thio)phenol-carboxylic acids and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 EP claimed
EP-0905123-B1 o-amino(thio)phenol-carboxylic acids and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 EP claimed
US-6310238-B1 INTERMEDIATES FOR THE PREPARATION OF POLYBENZOXAZOLES AND POLYBENZOTHIAZOLES SIEMENS AKTIENGESELLSCHAFT (DE) 2001-10-30 US claimed
US-6096921-A USED FOR THE PREPARATION OF HIGH-TEMPERATURE-STABLE POLYMERS, SUCH AS POLYBENZOXAZOLES AND POLYBENZTHIAZOLES SIEMENS AKTIENGESELLSCHAFT (DE) 2000-08-01 US claimed
US-5998662-A O-amino (thio) phenolcarboxylic acids and their preparation SIEMENS AKTIENGESELLSCHAFT (DE) 1999-12-07 US claimed
JP-9235279-A None JP disclosed
JP-11171995-A None JP disclosed
JP-10245371-A None JP disclosed
US-12245446-B2 Semiconductor device having quantum dots, display device, imaging system, and moving body CANON KABUSHIKI KAISHA (JP) 2025-03-04 US disclosed
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 EP disclosed
CN-113285024-A Semiconductor device having quantum dots, display device, imaging system, and moving object 佳能株式会社 2021-08-20 CN disclosed
JP-H09235279-A 3-AMINO-2-MERCAPTOBENZOIC ACID DERIVATIVE AND ITS PRODUCTION CIBA GEIGY AG 1997-09-09 JP disclosed
CN-1156722-A 3-amino-2-mercaptobenzoic acid derivatives and process for preparing same CIBA GEIGY AG (CH) 1997-08-13 CN disclosed
CN-1156722-A 3-amino-2-mercaptobenzoic acid derivatives and process for preparing same CIBA GEIGY AG (CH) 1997-08-13 CN disclosed
EP-0780372-A2 3-Amino-2-mercaptobenzoic acid derivatives and processes for their preparation Novartis AG (CH) 1997-06-25 EP disclosed
EP-0780372-A2 3-Amino-2-mercaptobenzoic acid derivatives and processes for their preparation Novartis AG (CH) 1997-06-25 EP disclosed
EP-0472783-A1 Anti-tumor compositions and compounds PHARMACHEMIE B.V. (NL) 1992-03-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid TPMT, PAH, AADAT MMP2 3712/4885MAPT 3652/4885G6PD 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.